Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic i Provincial, Barcelona, Spain.
Gut. 2011 Apr;60(4):517-24. doi: 10.1136/gut.2010.220913. Epub 2010 Nov 26.
The transcription factor Kruppel-like factor 2 (KLF2) modulates the expression of multiple endothelial vasoprotective genes. In the absence of KLF2, the endothelial phenotype becomes dysfunctional. To date, blood-derived shear stress is the main physiological stimulus identified to trigger and sustain endothelial KLF2 expression. Portal hypertension is a common complication of cirrhosis. Sinusoidal distortion and endothelial dysfunction play a significant role in its pathogenesis. This study aimed to assess whether abnormal intrahepatic haemodynamics in cirrhosis could modify KLF2 expression and consequently its downstream transcriptional programmes.
Rats received carbon tetrachloride or vehicle for two (acute injury), six (early cirrhosis) and twelve weeks (advanced cirrhosis). Systemic and hepatic haemodynamic parameters were measured in vivo. Hepatic expression of KLF2 and its vasoprotective targets were determined. Additionally, KLF2 expression was determined in liver sections, in freshly-isolated hepatic endothelial cells, and in livers from simvastatin-treated cirrhotic animals.
Cirrhotic livers have increased endothelial KLF2 expression compared with controls. KLF2 elevation, observed at six weeks of cirrhosis induction, was accompanied by a parallel increase in portal pressure and an increase in the expression of its target genes eNOS, thrombomodulin and CNP. Simvastatin administration further increased hepatic KLF2 and target genes expression.
This study shows an increase in the expression of the vasoprotective transcription factor KLF2 in the cirrhotic liver, accompanied by an activation of its downstream transcriptional programmes. These data suggest that the marked increase in KLF2 expression may represent an endothelial compensatory mechanism to improve the ongoing vascular dysfunction in the cirrhotic liver.
转录因子 Kruppel 样因子 2(KLF2)调节多种内皮血管保护基因的表达。在缺乏 KLF2 的情况下,内皮表型变得功能失调。迄今为止,血液来源的切应力是被确定触发和维持内皮细胞 KLF2 表达的主要生理刺激。门静脉高压是肝硬化的常见并发症。窦状变形和内皮功能障碍在其发病机制中起重要作用。本研究旨在评估肝硬化中异常的肝内血液动力学是否可以改变 KLF2 的表达及其下游转录程序。
大鼠接受四氯化碳或载体 2 周(急性损伤)、6 周(早期肝硬化)和 12 周(晚期肝硬化)。体内测量全身和肝血流动力学参数。测定 KLF2 及其血管保护靶基因在肝内的表达。此外,还在肝组织切片、新鲜分离的肝内皮细胞和辛伐他汀治疗的肝硬化动物肝脏中测定 KLF2 的表达。
与对照组相比,肝硬化肝脏的内皮 KLF2 表达增加。在肝硬化诱导 6 周时观察到的 KLF2 升高伴随着门静脉压力的平行升高和其靶基因 eNOS、血栓调节蛋白和 CNP 的表达增加。辛伐他汀给药进一步增加了肝 KLF2 和靶基因的表达。
本研究表明,在肝硬化肝脏中,血管保护转录因子 KLF2 的表达增加,同时其下游转录程序被激活。这些数据表明,KLF2 表达的显著增加可能代表内皮细胞的代偿机制,以改善肝硬化肝脏中持续存在的血管功能障碍。